C Vlachopoulos, D Terentes-Printzios, N … - Current Pharmaceutical Design, 2009 - ingentaconnect.com Abstract: Phosphodiesterase type-5 (PDE5) inhibitors are widely used as
first-line therapy for erectile dysfunction (ED). Their efficacy and safety
combined with an increasing understanding of cyclic guanosine monophosphate ... Cited by 2 - Related articles
SS Hayreh - British Journal of Ophthalmology, 2008 - bjo.bmj.com I have investigated this comprehensively, experimentally and clinically, since
1969. Those studies have shown that NA-AION is multifactorial in nature, that
is, many risk factors collectively play a role in its development. The risk ... Cited by 1 - Related articles - All 4 versions
V Sehstörungen - Springer Sildenafilcitrat ist ein selektiver Inhibitor des zyklischen Guanosinmono-
phosphats (cGMP) der Phosphodiesterase Typ 5 (PDE5). Die Phospho- diesterase
(PDE6) befindet sich in hohen Konzentrationen in Zapfen und Stäbchen der ... Related articles